AceReport Image
SHOULDER & ELBOW
Recombinant human growth hormone injection does not improve healing rate versus control in RC repair
Verified
This report has been verified by one or more authors of the original publication.
J Shoulder Elbow Surg. 2018 May;27(5):777-785

91 patients scheduled for arthroscopic rotator cuff repair were randomized to either postoperative injections of weekly 4mg or 8mg recombinant human growth hormone (rhGH), or to a control with no postoperative injections. Patients were assessed for healing rate using the Sugaya classification, fatty infiltration and atrophy on MRI, and for clinical scores and range of motion over the first 6 months after surgery. Results demonstrated no significant differences between groups for any of the above outcome measures.

Unlock the full ACE Report

You have access to {0} free articles per month.
Click below to unlock and view this {1}
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
{0} of {1} free articles

Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.

Upgrade Now
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade Account
Upgrade
Search
Close Search Window
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Recombinant human growth hormone injection does not improve healing rate versus control in RC repair. ACE Report. 2019;9(2):72. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report